What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
His scientific interests lie mostly in Internal medicine, Endocrinology, Diabetes mellitus, Cardiology and Coronary artery disease.
His Internal medicine study typically links adjacent topics like Surgery.
His Endocrinology research focuses on subjects like Myocardial infarction, which are linked to Compound heterozygosity, Missense mutation, Reverse cholesterol transport and Incidence.
Amit Khera works mostly in the field of Diabetes mellitus, limiting it down to topics relating to Confidence interval and, in certain cases, Biomarker and Vascular disease.
His study in Cardiology is interdisciplinary in nature, drawing from both JUPITER trial, Intervention trial, Diastole, Rosuvastatin and Cohort.
His Coronary artery disease research is multidisciplinary, relying on both Multifactorial Inheritance, High-density lipoprotein and Pioglitazone.
His most cited work include:
- Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association (2359 citations)
- Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis (1422 citations)
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (1112 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Cardiology, Endocrinology, Coronary artery disease and Disease.
Amit Khera frequently studies issues relating to Diabetes mellitus and Internal medicine.
The concepts of his Cardiology study are interwoven with issues in Cohort, Hazard ratio, Confidence interval and Atherosclerotic cardiovascular disease.
His work on Endocrinology is being expanded to include thematically relevant topics such as Case-control study.
Coronary artery disease is frequently linked to Bioinformatics in his study.
His Disease research is multidisciplinary, incorporating elements of Genetics, Genetic variation, Risk factor and Intensive care medicine.
He most often published in these fields:
- Internal medicine (70.28%)
- Cardiology (37.58%)
- Endocrinology (23.14%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (70.28%)
- Disease (16.35%)
- Cardiology (37.58%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Disease, Cardiology, Genetics and Coronary artery disease.
His study in Internal medicine focuses on Atherosclerotic cardiovascular disease, Familial hypercholesterolemia, Myocardial infarction, Lipoprotein and Family history.
In his work, Primary prevention and Statin is strongly intertwined with Intensive care medicine, which is a subfield of Disease.
His work investigates the relationship between Cardiology and topics such as Hazard ratio that intersect with problems in Cohort.
His study in the field of Genome-wide association study, Genetic variation and Consanguinity is also linked to topics like Founder effect.
His research integrates issues of Odds ratio, Genome, Gastroenterology and Coronary heart disease in his study of Coronary artery disease.
Between 2019 and 2021, his most popular works were:
- A structural variation reference for medical and population genetics (125 citations)
- A structural variation reference for medical and population genetics (125 citations)
- Race, socioeconomic deprivation, and hospitalization for COVID-19 in English participants of a national biobank. (39 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Internal medicine, Disease, MEDLINE, Familial hypercholesterolemia and Cardiology are his primary areas of study.
His research links Endocrinology with Internal medicine.
His work deals with themes such as Telehealth, Rehabilitation, Ambulatory care and Intensive care medicine, which intersect with Disease.
While the research belongs to areas of MEDLINE, Amit Khera spends his time largely on the problem of Exome, intersecting his research to questions surrounding Biobank.
His Familial hypercholesterolemia research incorporates themes from Penetrance, Breast cancer and Genetic variation.
His study in the field of Heart failure and Heart transplantation also crosses realms of COAGULATION FACTOR X.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
